Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Rev Med Interne ; 27(10): 791-3, 2006 Oct.
Artigo em Francês | MEDLINE | ID: mdl-16978747

RESUMO

INTRODUCTION: Down syndrome is a favourable land to the emergence of auto-immune disease. CASE RECORD: Graves' disease and celiac disease were diagnosed in a 16 years old adolescent with Down syndrome presenting chronic diarrhoea, important delayed development and signs of hyperthyroidism. DISCUSSION: Celiac disease and thyroid dysfunction would be screening in patient with Down syndrome.


Assuntos
Doença Celíaca/complicações , Síndrome de Down/complicações , Doença de Graves/complicações , Adolescente , Doença Celíaca/diagnóstico , Síndrome de Down/diagnóstico , Feminino , Doença de Graves/diagnóstico , Humanos
2.
Ann Urol (Paris) ; 34(4): 254-65, 2000 Aug.
Artigo em Francês | MEDLINE | ID: mdl-10994145

RESUMO

Prostatic cancer has a great predilection for bone. The evaluation of its extension towards the skeleton is based on the bone scan, which has a better sensitivity than radiological examinations and clinical evaluation. Bone scan evaluation of the osseous extension, allowed a better comprehension of the mechanism of dissemination, the assumption of Batson appearing currently not very plausible. The importance of the osseous extension on the bone scan has a prognostic value; it constitutes one of the significant parameters of stratification in clinical trials. The indications of bone scan have been greatly modified since the introduction of prostate-specific antigen (PSA). At the initial assessment, the of bone scan should be indicated only if the rate of PSA exceeds 10-20 ng/mL, in the event of low grade tumor and pain. In the follow-up, the evolution of the PSA constitutes the major element of monitoring. After radical therapy, a rise in the PSA indicates bone scan, particularly if the level exceeds 10 ng/mL. In stage D2, routine bone scan is no longer indicated, except in phases II and III of the clinical trials.


Assuntos
Osso e Ossos/diagnóstico por imagem , Neoplasias da Próstata/diagnóstico por imagem , Humanos , Masculino , Estadiamento de Neoplasias/métodos , Neoplasias da Próstata/patologia , Tomografia Computadorizada de Emissão
3.
Ann Urol (Paris) ; 36(1): 8-21, 2002 Jan.
Artigo em Francês | MEDLINE | ID: mdl-11859584

RESUMO

The diuresis renography has an important place in the management of upper urinary tract dilatation in children. This non-aggressive and low irradiant exploration is very helpful to determine if hydronephrosis is obstructive or not and to evaluate the renal function impairment. The protocol of exam must be particularly rigorous and interpretation should take into account physiopathological factors that influence provocated diuresis. A well patient hydration and if necessary a bladder catheter are required. The MAG-3 is the radiopharmaceutical of choice especially in newborn and infants. The furosemide administration at 20 minutes after radiotracer injection is the most commonly used protocol and is generally sufficient to classify the urinary dilatation. Equivocal cases and symptomatic forms can benefit from a modified protocol in which furosemide is administered 15 minutes before radiotracer injection (F-15). False positive tests may result from a marked dilatation or renal function reduction. The place of diuresis renography in management of neonatal hydronephrosis is controversial, particularly because of the dynamic and evolving nature of this pathology.


Assuntos
Diuréticos , Nefropatias/diagnóstico por imagem , Criança , Pré-Escolar , Diagnóstico Diferencial , Dilatação Patológica/diagnóstico por imagem , Reações Falso-Positivas , Furosemida , Humanos , Hidronefrose/diagnóstico por imagem , Lactente , Recém-Nascido , Cintilografia
4.
Trop Biomed ; 28(3): 615-9, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22433891

RESUMO

We report a case of fatal congenital toxoplasmosis case in Tunis (North of Tunisia) associated with I/III recombinant genotype. The Toxoplasma gondii strain was isolated from placenta and characterized molecularly by a multilocus typing (3'SAG2, 5'SAG2, SAG3, AK69, APICO, and UPRT1) and a sulfadiazine resistance mutation analysis. The isolate was shown to be a wild drug sensitive I/III recombinant strain.


Assuntos
Recombinação Genética , Toxoplasma/classificação , Toxoplasma/genética , Toxoplasmose Congênita/diagnóstico , Toxoplasmose Congênita/parasitologia , Adulto , Antiprotozoários/farmacologia , DNA de Protozoário/genética , Feminino , Genótipo , Humanos , Recém-Nascido , Tipagem de Sequências Multilocus , Testes de Sensibilidade Parasitária , Placenta/parasitologia , Gravidez , Sulfadiazina/farmacologia , Toxoplasma/isolamento & purificação , Tunísia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA